Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof

US12157737B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Mallesh BUSHABOINA · Bengaluru, IN
• Xin Chen · Lexington, US
• Atwood Kim CHEUNG · Arlington, US
• Andrew James Culshaw · Horsham, GB
• Timothy Brian HURLEY · Boston, US
• Nancy LABBE-GIGUERE · Arlington, US
• Wolfgang Miltz · Basel, CH
• David Orain · Hésingue, FR
• Tajesh Jayprakash Patel · Medford, US
• Srinivasan Rajagopalan · Bengaluru, IN
• Till Roehn · Zürich, CH
• David Andrew Sandham · Horsham, GB
• Gebhard Thoma · Lörrach, DE
• Ritesh Bhanudasji Tichkule · Cambridge, US
• Rudolf Walchli · Basel, CH

Key dates

• Filing date: May 18, 2023
• Grant date: Dec 3, 2024
• Expiry date: May 18, 2043

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof;